Park Suho, Cho Yunjoo, Kim Hyun-Soo
Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
Anticancer Res. 2023 Oct;43(10):4559-4571. doi: 10.21873/anticanres.16650.
BACKGROUND/AIM: The expression of L1 cell adhesion molecule (L1CAM) in uterine mesonephric-like adenocarcinoma (MLA) remains understudied. Our aim was to explore the L1CAM expression in uterine MLA, delving into its clinicopathological implications and prognostic significance.
We conducted L1CAM immunostaining in MLA, endometrioid carcinoma (EC), and serous carcinoma (SC), compared L1CAM expression across these histological types, and probed the relationship between L1CAM expression and the clinicopathological features and outcomes of patients with MLA.
High L1CAM expression was evident in 15 of 28 MLA cases (53.6%). This rate surpassed that of EC (7.5%) but was less than that of SC (78.9%). A high L1CAM expression correlated with initial distant metastasis, advanced initial stage, lung metastasis, and the recurrence of MLA. L1CAM-high MLA exhibited worse disease-free and overall survival than L1CAM-low MLA.
L1CAM over-expression was observed in more than half of the MLA cases, and was associated with aggressive clinicopathological traits and adverse outcomes in patients with uterine MLA.
背景/目的:子宫中肾样腺癌(MLA)中L1细胞粘附分子(L1CAM)的表达仍未得到充分研究。我们的目的是探讨L1CAM在子宫MLA中的表达,深入研究其临床病理意义和预后意义。
我们对MLA、子宫内膜样癌(EC)和浆液性癌(SC)进行了L1CAM免疫染色,比较了这些组织学类型中L1CAM的表达情况,并探讨了L1CAM表达与MLA患者临床病理特征及预后之间的关系。
28例MLA病例中有15例(53.6%)L1CAM高表达。这一比例超过了EC(7.5%),但低于SC(78.9%)。L1CAM高表达与初始远处转移、晚期初始阶段、肺转移及MLA复发相关。L1CAM高表达的MLA患者无病生存期和总生存期均较L1CAM低表达的MLA患者差。
超过半数的MLA病例中观察到L1CAM过表达,且其与子宫MLA患者侵袭性临床病理特征及不良预后相关。